FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000825812> ?p ?o ?g. }

• W2000825812 endingPage "519" @default.
• W2000825812 startingPage "511" @default.
• W2000825812 abstract "Background Abuse of heroin and prescription opiate medications has grown to disturbing levels. Opioids mediate their effects through mu opioid receptors (MOR), but minimal information exists regarding MOR-related striatal signaling relevant to the human condition. The striatum is a structure central to reward and habitual behavior and neurobiological changes in this region are thought to underlie the pathophysiology of addiction disorders. Methods We examined molecular mechanisms related to MOR in postmortem human brain striatal specimens from a homogenous European Caucasian population of heroin abusers and control subjects and in an animal model of heroin self-administration. Expression of ets-like kinase 1 (ELK1) was examined in relation to polymorphism of the MOR gene OPRM1 and drug history. Results A characteristic feature of heroin abusers was decreased expression of MOR and extracellular regulated kinase signaling networks, concomitant with dysregulation of the downstream transcription factor ELK1. Striatal ELK1 in heroin abusers associated with the polymorphism rs2075572 in OPRM1 in a genotype dose-dependent manner and correlated with documented history of heroin use, an effect reproduced in an animal model that emphasizes a direct relationship between repeated heroin exposure and ELK1 dysregulation. A central role of ELK1 was evidenced by an unbiased whole transcriptome microarray that revealed ~20% of downregulated genes in human heroin abusers are ELK1 targets. Using chromatin immune precipitation, we confirmed decreased ELK1 promoter occupancy of the target gene Use1. Conclusions ELK1 is a potential key transcriptional regulatory factor in striatal disturbances associated with heroin abuse and relevant to genetic mutation of OPRM1. Abuse of heroin and prescription opiate medications has grown to disturbing levels. Opioids mediate their effects through mu opioid receptors (MOR), but minimal information exists regarding MOR-related striatal signaling relevant to the human condition. The striatum is a structure central to reward and habitual behavior and neurobiological changes in this region are thought to underlie the pathophysiology of addiction disorders. We examined molecular mechanisms related to MOR in postmortem human brain striatal specimens from a homogenous European Caucasian population of heroin abusers and control subjects and in an animal model of heroin self-administration. Expression of ets-like kinase 1 (ELK1) was examined in relation to polymorphism of the MOR gene OPRM1 and drug history. A characteristic feature of heroin abusers was decreased expression of MOR and extracellular regulated kinase signaling networks, concomitant with dysregulation of the downstream transcription factor ELK1. Striatal ELK1 in heroin abusers associated with the polymorphism rs2075572 in OPRM1 in a genotype dose-dependent manner and correlated with documented history of heroin use, an effect reproduced in an animal model that emphasizes a direct relationship between repeated heroin exposure and ELK1 dysregulation. A central role of ELK1 was evidenced by an unbiased whole transcriptome microarray that revealed ~20% of downregulated genes in human heroin abusers are ELK1 targets. Using chromatin immune precipitation, we confirmed decreased ELK1 promoter occupancy of the target gene Use1. ELK1 is a potential key transcriptional regulatory factor in striatal disturbances associated with heroin abuse and relevant to genetic mutation of OPRM1." @default.
• W2000825812 created "2016-06-24" @default.
• W2000825812 creator A5003106584 @default.
• W2000825812 creator A5017402123 @default.
• W2000825812 creator A5022637693 @default.
• W2000825812 creator A5025307452 @default.
• W2000825812 creator A5026980434 @default.
• W2000825812 creator A5032672419 @default.
• W2000825812 creator A5032951414 @default.
• W2000825812 creator A5042652602 @default.
• W2000825812 creator A5065749422 @default.
• W2000825812 creator A5066123551 @default.
• W2000825812 creator A5083825817 @default.
• W2000825812 creator A5087793851 @default.
• W2000825812 date "2013-10-01" @default.
• W2000825812 modified "2023-10-16" @default.
• W2000825812 title "ELK1 Transcription Factor Linked to Dysregulated Striatal Mu Opioid Receptor Signaling Network and OPRM1 Polymorphism in Human Heroin Abusers" @default.
• W2000825812 cites W1480859226 @default.
• W2000825812 cites W1492294380 @default.
• W2000825812 cites W1494401713 @default.
• W2000825812 cites W1917554980 @default.
• W2000825812 cites W1932157592 @default.
• W2000825812 cites W1965843675 @default.
• W2000825812 cites W1966052367 @default.
• W2000825812 cites W1967318257 @default.
• W2000825812 cites W1975031360 @default.
• W2000825812 cites W1982289936 @default.
• W2000825812 cites W1983455097 @default.
• W2000825812 cites W1988633934 @default.
• W2000825812 cites W1989717309 @default.
• W2000825812 cites W1991882455 @default.
• W2000825812 cites W1995830102 @default.
• W2000825812 cites W1996783118 @default.
• W2000825812 cites W1996811776 @default.
• W2000825812 cites W1997230612 @default.
• W2000825812 cites W1997572235 @default.
• W2000825812 cites W1998863234 @default.
• W2000825812 cites W2000082154 @default.
• W2000825812 cites W2001891260 @default.
• W2000825812 cites W2003726800 @default.
• W2000825812 cites W2008264529 @default.
• W2000825812 cites W2008935385 @default.
• W2000825812 cites W2011895147 @default.
• W2000825812 cites W2012743573 @default.
• W2000825812 cites W2015087988 @default.
• W2000825812 cites W2015577475 @default.
• W2000825812 cites W2015609730 @default.
• W2000825812 cites W2017514322 @default.
• W2000825812 cites W2018705639 @default.
• W2000825812 cites W2023652011 @default.
• W2000825812 cites W2033232160 @default.
• W2000825812 cites W2036768211 @default.
• W2000825812 cites W2037276920 @default.
• W2000825812 cites W2037444729 @default.
• W2000825812 cites W2037917849 @default.
• W2000825812 cites W2042317651 @default.
• W2000825812 cites W2045441934 @default.
• W2000825812 cites W2051746492 @default.
• W2000825812 cites W2063017492 @default.
• W2000825812 cites W2063121143 @default.
• W2000825812 cites W2070884432 @default.
• W2000825812 cites W2079516818 @default.
• W2000825812 cites W2082722104 @default.
• W2000825812 cites W2086257923 @default.
• W2000825812 cites W2086535506 @default.
• W2000825812 cites W2088531907 @default.
• W2000825812 cites W2090488936 @default.
• W2000825812 cites W2091054811 @default.
• W2000825812 cites W2091283843 @default.
• W2000825812 cites W2092040369 @default.
• W2000825812 cites W2092099338 @default.
• W2000825812 cites W2098023402 @default.
• W2000825812 cites W2098031538 @default.
• W2000825812 cites W2099814519 @default.
• W2000825812 cites W2106726734 @default.
• W2000825812 cites W2108111134 @default.
• W2000825812 cites W2108856429 @default.
• W2000825812 cites W2109972881 @default.
• W2000825812 cites W2110751128 @default.
• W2000825812 cites W2112902993 @default.
• W2000825812 cites W2128016314 @default.
• W2000825812 cites W2130484730 @default.
• W2000825812 cites W2132620387 @default.
• W2000825812 cites W2135432300 @default.
• W2000825812 cites W2136982232 @default.
• W2000825812 cites W2137566501 @default.
• W2000825812 cites W2149902451 @default.
• W2000825812 cites W2153693979 @default.
• W2000825812 cites W2159777425 @default.
• W2000825812 cites W2161633633 @default.
• W2000825812 cites W2167219760 @default.
• W2000825812 cites W2168750820 @default.
• W2000825812 cites W2318619436 @default.
• W2000825812 doi "https://doi.org/10.1016/j.biopsych.2013.04.012" @default.
• W2000825812 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4070524" @default.
• W2000825812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23702428" @default.
• W2000825812 hasPublicationYear "2013" @default.
• W2000825812 type Work @default.

• next